Erector spinae muscle-based nomogram for predicting in-hospital mortality among older patients with severe community-acquired pneumonia
BMC Pulmonary Medicine volume 23, Article number: 346 (2023)
No multivariable model incorporating erector spinae muscle (ESM) has been developed to predict clinical outcomes in older patients with severe community-acquired pneumonia (SCAP). This study aimed to construct a nomogram based on ESM to predict in-hospital mortality in patients with SCAP.
Patients aged ≥ 65 years with SCAP were enrolled in this prospective observational study. Least absolute selection and shrinkage operator and multivariable logistic regression analyses were used to identify risk factors for in-hospital mortality. A nomogram prediction model was constructed. The predictive performance was evaluated using the concordance index (C-index), calibration curve, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis.
A total of 490 patients were included, and the in-hospital mortality rate was 36.1%. The nomogram included the following independent risk factors: mean arterial pressure, peripheral capillary oxygen saturation, Glasgow Coma Scale score (GCS), lactate, lactate dehydrogenase, blood urea nitrogen levels, and ESM cross-sectional area. Incorporating ESM into the base model with other risk factors significantly improved the C-index from 0.803 (95% confidence interval [CI], 0.761–0.845) to 0.836 (95% CI, 0.798–0.873), and these improvements were confirmed by category-free NRI and IDI. The ESM-based nomogram demonstrated a high level of discrimination, good calibration, and overall net benefits for predicting in-hospital mortality compared with the combination of confusion, urea, respiratory rate, blood pressure, and age ≥ 65 years (CURB-65), Pneumonia Severity Index (PSI), Acute Physiology and Chronic Health Evaluation II (APACHEII), and Sequential Organ Failure Assessment (SOFA).
The proposed ESM-based nomogram for predicting in-hospital mortality among older patients with SCAP may help physicians to promptly identify patients prone to adverse outcomes.
This study was registered at www.chictr.org.cn (registration number Chi CTR-2300070377).
With increasing life expectancy and decreasing birth rates, the proportion of adults aged 65 years and over will rise dramatically to 38% by the year 2050 . Community-acquired pneumonia (CAP) is the leading cause of death among older patients, and its incidence and mortality gradually increase with age [2,3,4]. Severe CAP (SCAP) is a major challenge in intensive care units (ICU); hospital mortality rates range from 25% to more than 50% and are higher among older adults [5, 6]. Mortality related to SCAP remains staggeringly high despite advances in rapid diagnosis, antibiotic coverage, and vaccine inoculation . The risk factors for mortality associated with SCAP include patient-related factors (e.g., age, comorbidities, vital signs), pathogen specificity, severity of illness, and related management processes (e.g., delays in ICU care) . Identification of risk factors at an early stage is crucial to prevent unnecessary mortality and enable timely intervention.
Sarcopenia is characterized by an age-related decline in skeletal muscle, muscle strength, and/or physical performance , which may contribute to a host of negative outcomes, including reduced functional capacity, falls, and even death in older people. A variety of imaging techniques are available for assessing muscle mass including dual-energy X-ray absorptiometry, bioelectrical impedance analysis, magnetic resonance imaging, and computed tomography (CT) . The cross-sectional area of the skeletal muscles at the level of the third lumbar vertebra on abdominal CT is conventionally used to investigate skeletal muscle characteristics . However, abdominal CT is not routinely performed in patients with respiratory diseases. Many studies have confirmed that the evaluation of thoracic skeletal muscles via chest CT can be used to measure sarcopenia. Recent studies have demonstrated that chest CT-derived cross-sectional areas of erector spinae muscles (ESMcsa) at the 12th thoracic level are associated with poor prognosis in patients with chronic obstructive pulmonary disease, severe novel coronavirus disease 2019 (COVID-19), and other respiratory diseases [11, 12]. Furthermore, ESMcsa may serve as a prognostic indicator for in-hospital mortality among patients with CAP or SCAP [13,14,15].
To date, there is no reliable evaluation tool for predicting adverse outcomes of SCAP in a timely manner. The predictive effects of laboratory biomarkers such as C-reactive protein and procalcitonin have been suggested as inadequate for clinical use in older patients with SCAP . Pneumonia severity scores such as the combination of confusion, urea, respiratory rate, blood pressure, and age ≥ 65 years (CURB-65); Pneumonia Severity Index (PSI); and critical illness scores such as the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA), among others, may not be accurate or applicable in emergency departments due to the complexity and time-consuming nature of the tests .
A chest CT, performed for diagnosis or assessment of therapeutic effects, is a routine examination modality for patients with SCAP, and ESMcsa is easily determined using chest CT without extra cost or radiation. However, to the best of our knowledge, no multivariable model incorporating ESMcsa has been developed to predict clinical outcomes in older patients with SCAP. Therefore, in the current study, we aimed to use basic clinical and laboratory indicators on admission, as well as ESMcsa determined from chest CT, to construct a simple ESM-based nomogram for predicting in-hospital mortality among older patients with SCAP. We then compared the predictive value of the novel nomogram with widely used scoring systems.
Study design and patients
This prospective observational cohort study included older patients (aged ≥ 65 years) with SCAP who were admitted to Beijing Chao-Yang Hospital between January 1, 2022, and November 30, 2022. During the study period, patients those who tested negative for COVID-19 were admitted. This study was approved by the Institutional Review Board of Beijing Chao-Yang Hospital Capital Medical University (2022-ke-430) and conducted in accordance with the Declaration of Helsinki and its later amendments. Written informed consent was obtained from each patient or their next of kin. We followed the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) guidelines  for our prognostic model and a completed TRIPOD checklist was provided as an additional file (Additional file 1).
The method of events per variable (EPV) was used to estimate the sample size. An EPV of 10 meant that each independent variable required 10 positive events. In this study, at least 100 positive events were needed if 10 candidate variables were expected to be included in the multivariable logistic regression model. Since the mortality rate of older patients with SCAP was reported approximately 30% , the sample size was at least 333. Considering the situation of missing data, an increase of 20% was required and the overall sample size was 400. A total of 490 older SCAP patients were enrolled in the current study.
The inclusion criteria were as follows: (1) age ≥ 65 years, and (2) a clinical diagnosis of SCAP according to the Infectious Diseases Society of America/American Thoracic Society consensus guidelines . SCAP was defined as fulfilment of at least one major criterion (septic shock with need for vasopressors, requirement for mechanical ventilation) or three minor criteria (respiratory rate ≥ 30 breaths/min, partial pressure of oxygen/fraction of inspired oxygen ratio ≤ 250, multilobar infiltrates, confusion/disorientation, blood urea nitrogen [BUN] level ≥ 20 mg/dL, white blood cell count < 4000 cells/µL, platelet count < 100,000/µL, hypothermia-core temperature < 36℃, hypotension requiring aggressive fluid resuscitation).
The exclusion criteria were as follows: (1) no chest CT scan within 24 h after hospitalization, (2) pre-existing or acute peripheral neuromuscular diseases, (3) history of thoracic vertebral surgery, (4) imaging data not of high quality, (5) incomplete clinical data, (6) repeated admission, (7) severe immunosuppression or immunosuppressive therapy, and (8) discharge within 24 h. All patients received standard therapeutic strategies based on the guidelines for SCAP during hospitalization .
Demographic variables, including age, sex, and body mass index (BMI); vital signs on admission (temperature, heart rate, respiratory rate, mean arterial pressure [MAP], and peripheral capillary oxygen saturation [SpO2]); and chronic diseases (hypertension, diabetes mellitus, coronary artery disease, chronic kidney disease, cerebrovascular disease, chronic liver disease, chronic pulmonary disease, and cancer) were collected. Baseline ESMcsa, complete blood counts, biochemical parameters, coagulation indicators, and arterial blood gas analysis results were measured within 24 h of admission. Mechanical ventilation and vasoactive agents were not evaluated in our study because these interventions may not have been performed on admission. The CURB-65, PSI, APACHE II, and SOFA scores were independently assessed by two emergency physicians. Functional and frailty statuses were evaluated using the Barthel index and Clinical Frailty Scale (CFS), respectively. All data were recorded within 24 h of admission.
Chest CT scans
Plain chest CT scans were performed and reconstructed using a 1.25-mm slice thickness. The presence of hydrothorax and multilobar infiltration was noted, and ESMcsa was determined based on the chest CT. The quantitative assessment of ESMcsa was conducted using an AW Volume Share 7 workstation (GE Medical Systems S.C.S) retrieved from the institutional Picture Archiving and Communication System. The CT histogram software X Section was used to manually delineate the region of interest (ROI); this software calculates the ROI area automatically. The Hounsfield unit (HU) thresholds were set from –29 HU to + 150 HU, which are consistent with skeletal muscle density. ESMcsa was measured at the inferior margin of the 12th thoracic vertebra within 24 h. The bilateral ESMcsa values were summed to determine the total ESMcsa value. All measurements were obtained, and the averages were calculated by one of two trained emergency physicians.
The primary outcome was all-cause mortality during hospitalization.
Continuous variables were presented as medians (interquartile ranges [IQR]) for non-normally distributed variables and as means (standard deviations) for normally distributed variables. Categorical variables were presented as numbers (percentages). Baseline characteristics were compared between survivors and non-survivors using the Mann–Whitney U test, Student’s t-test, or chi-square test, as appropriate. Multiple imputations were used to account for missing variables if the missing values were < 20%. Least absolute selection and shrinkage operator (LASSO) and multivariable logistic regressions were applied to select possible predictive variables, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. A forward stepwise selection procedure was performed; the independent variables remaining in the multivariable logistic regression model were used to construct the nomogram. The discriminatory ability of the nomogram was assessed using the concordance index (C-index) (also named the area under the receiver operating characteristic curve [AUC]), and 1000 bootstrap resamples were used for internal validation. A calibration plot was constructed, and the Hosmer–Lemeshow goodness-of-fit test and Brier score were calculated. Decision curve analysis (DCA) was used to measure the net benefit of the nomogram. The C-index and DCA of the nomogram were compared with those of the base model, CURB-65, PSI, APACHE II, and SOFA. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were used to compare the discrimination slopes. All data were analyzed using SPSS (version 26.0; SPSS Inc., Chicago, IL, USA) and R software (version 4.2.0; The R Foundation for Statistical Computing). All P-values were two-tailed, and P < 0.05 was considered statistically significant.
A total of 490 older patients with SCAP were included in this study based on the inclusion and exclusion criteria (Fig. 1). The overall in-hospital mortality rate was 36.1% (177/490). Among all patients, 293 (59.8%) were men, the median age was 80.0 years (IQR, 16.0), and the median BMI was 23.0 kg/m2 (IQR, 3.7). The baseline data are shown in Table 1. There were significant differences in age, heart rate, MAP, SpO2, ESMcsa, comorbidities (including diabetes mellitus, cerebrovascular disease, chronic pulmonary disease, and cancer), and the Glasgow Coma Scale (GCS), Barthel index, CFS, CURB-65, PSI, APACHE II, and SOFA scores between survivors and non-survivors.
Development of the nomogram
The LASSO regression model included 59 candidate variables measured upon admission: age, sex, BMI, vital signs, comprehensive geriatric assessment, comorbidities, arterial blood gas analysis results, complete blood cell count, liver and renal function, electrolyte concentrations, coagulation test results, procalcitonin concentration, hydrothorax, multilobar infiltration, and ESMcsa. Further LASSO regression analysis resulted in the identification of 10 variables that were associated with in-hospital mortality: MAP, SpO2, GCS, CFS, red blood cell distribution width, ESMcsa, and lactate dehydrogenase (LDH), lactate, BUN, and potassium levels. The 10 variables were entered into multivariable logistic regression models, and seven variables remained statistically significant. A nomogram model was developed using these seven predictors: MAP (OR, 0.986; 95% CI, 0.974–0.998; P = 0.023), SpO2 (OR, 0.959; 95% CI, 0.937–0.982; P < 0.001), GCS (OR, 0.855; 95% CI, 0.809–0.903; P < 0.001), lactate (OR, 1.191; 95% CI, 1.047–1.354; P = 0.008), LDH (OR, 1.004; 95% CI, 1.002–1.005; P < 0.001), BUN (OR, 1.030; 95% CI, 1.008–1.052; P = 0.007), and ESMcsa (OR, 0.915; 95% CI, 0.886–0.946; P < 0.001) (Table 2). According to the nomogram, each predictor corresponded to a point and the total points was obtained by summing them. The predictive risk corresponding to the total points was the probability of in-hospital mortality in older patients with SCAP (Fig. 2A).
Performance of the nomogram
The C-index of the base model (with risk factors including MAP, SpO2, GCS, LDH, lactate, and BUN) was 0.803 (95% CI, 0.761–0.845). Compared with that of the base model, the ESM-based nomogram significantly improved the prediction of in-hospital mortality and had a C-index of 0.836 (95% CI, 0.798–0.873; P = 0.005), an NRI of 0.132 (95% CI, 0.044–0.217; P = 0.003), and an IDI of 0.051 (95% CI, 0.030–0.071; P < 0.001). The C-index indicated that the nomogram had good prediction accuracy for in-hospital mortality. The bias-corrected C-index was 0.826 based on bootstrapping validation. The calibration curve indicated good consistency between the predicted and observed probabilities with a Brier score of 0.154 (Fig. 2B). The Hosmer–Lemeshow goodness-of-fit test showed a chi-square of 0.700 and a P-value of 0.705. The predictive value of the ESM-based nomogram was higher than that of the CURB-65, PSI, APACHE II, and SOFA scoring systems, which had C-indices of 0.669 (95% CI, 0.622–0.715), 0.704 (95% CI, 0.654–0.754), 0.740 (95% CI, 0.693–0.786), and 0.778 (95% CI, 0.737–0.819), respectively. In addition, NRI and IDI showed that the novel ESM-based nomogram exhibited a superior performance compared with that of the other scoring systems (Fig. 3A, Table 3). DCA showed that the nomogram had a greater net clinical benefit than that of the other scoring systems within a wide range of threshold probabilities (Fig. 3B).
In this study, we constructed a new nomogram based on ESM to predict in-hospital mortality among older patients with SCAP. This nomogram, which incorporated ESM into the base model and included routine clinical characteristics and laboratory indicators, showed a significantly better predictive performance than that of CURB-65, PSI, APACHE II, and SOFA. To our knowledge, this is the first report of a multivariable predictive model that includes skeletal muscle mass measurements and other readily available parameters in older patients with SCAP.
SCAP is associated with significant morbidity and mortality and poses a major threat to older adults. To date, several scoring systems and models have been developed to predict adverse outcomes of SCAP; however, none have been fully validated or ready for implementation in clinical practice. Among these models and scoring systems, CURB-65 and PSI are the most widely used prognostic prediction systems. However, their performance for in-hospital mortality (AUCs < 0.7) is not optimal in older adult patients with SCAP [17, 21, 22]. Several studies have shown that the CURB-65 has limited negative and positive predictive values, especially in patients aged 70 years and over [23, 24]. Consistent with previous studies, our study revealed low predictive abilities for both CURB-65 and PSI, which had AUCs of 0.669 (95% CI, 0.622– 0.715) and 0.704 (95% CI, 0.654–0.754), respectively. This result was attributed to our study population, which consisted of older patients with a median age of 80.0 years (IQR, 16.0). Although some studies have reported that ICU scoring systems, such as the APACHE II and SOFA, are superior to other severity scores in predicting SCAP mortality or CAP disease severity [25, 26], these systems are complicated and include some interventions that are not feasible within 24 h of SCAP onset.
The older population is growing rapidly worldwide , and it is essential to develop a specific assessment tool for older patients with SCAP. Previous studies have suggested that age-related parameters, including functional status, frailty assessment, malnutrition, and other geriatric syndromes, are strongly associated with poor prognosis in patients with CAP [28,29,30]. Sarcopenia is a relatively newly recognized geriatric syndrome in the geriatric population; therefore, minimal evidence is available regarding the association between sarcopenia and pneumonia . One possible reason for this is that patients with SCAP are critically ill and unable to complete grip strength tests or the Short Physical Performance Battery. Although sarcopenia cannot be easily diagnosed in critically ill patients, muscle measurements can be readily obtained using CT scans. Additionally, bed rest and physical inactivity during hospitalization contribute to reduced muscle mass and decreased functional capacity in older adults. Low skeletal muscle mass has been associated with a poor prognosis of SCAP. Therefore, in our study, the measurement of muscle mass derived from chest CT was added to a multivariable model to explore its predictive effect on SCAP. As sarcopenia is highly associated with frailty and functional aspects, we also integrated the CFS (due to its feasibility) and the Barthel index to identify the frailty and functional status (basic activities of daily living), respectively [32, 33]. However, these two measures were not included in our multivariable model. Rather, we incorporated ESMcsa into the base model. Incorporating ESMsca into the base model, along with other risk factors, significantly improved its predictive accuracy. These findings indicate that clinicians should be mindful of muscle mass as determined using chest CT scans in clinical practice.
Our nomogram also included MAP, SpO2, GCS, LDH, lactate, and BUN. As components of the vital signs on admission, MAP and SpO2 data were readily available. Other studies have indicated that the systolic blood pressure or oxygenation index is associated with a poor prognosis of CAP [34, 35], which is consistent with our results. The GCS is the most widely used tool for consciousness assessment. Several studies have demonstrated that GCS is an independent prognostic factor for hospital mortality in ICU patients with lung infections [21, 35, 36]. LDH is a cytoplasmic enzyme that is widely distributed in major organs, including the lungs, kidneys, and skeletal muscles, and elevated serum LDH levels have been associated with SCAP and other respiratory diseases [37, 38]. The lactate level at admission is considered a rapid, inexpensive, and broadly available prognostic predictor that is independent of the CURB-65 scores for patients with CAP . High lactate levels indicate organ failure and hypoperfusion and have been suggested as a guide to fluid resuscitation in critically ill patients [39, 40]. Furthermore, septic shock is defined as hyperlactatemia (lactate level > 2 mmol/L), and requires vasopressor administration to maintain a MAP of 65 mmHg . Consistent with previous models and pneumonia severity scores such as the CURB-65 and PSI, our study showed that BUN was an important predictor of SCAP. Owing to study population heterogeneity, different predictive models have included various indicators of mortality in patients with SCAP.
Several limitations should be considered when interpreting the results of our study. First, this study was carried out in a single center with a small cohort of patients and chest CT is performed in most patients with pneumonia but not all, potentially contributing to selection bias. Second, not all potential risk factors were analyzed in our study, and some intervention parameters pertaining to mechanical ventilation and the use of vasopressors and antibiotics were excluded; these variables may not have been obtained in the early hospitalization course. Last, although the predictive accuracy of the nomogram was proven through internal validation, the data lacked external validity. Multicenter data should be considered in future studies to improve the robustness and performance of the nomogram model.
A novel nomogram, which included MAP, SpO2, GCS, LDH, lactate, BUN, and ESMcsa determined from chest CT, was developed and validated to predict in-hospital mortality among older patients with SCAP. The predictive nomogram had a superior performance compared to the CURB-65, PSI, APACHE II, and SOFA scores. Our nomogram is a potentially useful tool that may help clinicians perform medical interventions in a timely manner and prevent adverse outcomes in older patients with SCAP.
Availability of data and materials
The data used during the current study are available from the corresponding author upon reasonable request.
- APACHE II:
Acute Physiology and Chronic Health Evaluation II
Blood urea nitrogen
Clinical Frailty Scale
Cross-sectional area of erector spinae muscle
Erector spinae muscle
Intensive care unit
Integrated discrimination improvement
Glasgow coma scale
Mean arterial pressure
Net reclassification improvement
Pneumonia Severity Index
Severe community-acquired pneumonia
Sequential Organ Failure Assessment
- SpO2 :
Peripheral capillary oxygen saturation
Rudnicka E, Napierała P, Podfigurna A, et al. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6–11. https://doi.org/10.1016/j.maturitas.2020.05.018.
Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly: age-and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165(6):766–72. https://doi.org/10.1164/ajrccm.165.6.2103038.
Sun Y, Li H, Pei Z, et al. Incidence of community-acquired pneumonia in urban China: a national population-based study. Vaccine. 2020;38(52):8362–70. https://doi.org/10.1016/j.vaccine.2020.11.004.
Han X, Zhou F, Li H, et al. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia. BMC Infect Dis. 2018;18(1):192. https://doi.org/10.1186/s12879-018-3098-5.
Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther. 2021;217:107663. https://doi.org/10.1016/j.pharmthera.2020.107663.
Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020;37(4):1302–18. https://doi.org/10.1007/s12325-020-01248-7.
Torres A, Chalmers JD, Dela Cruz CS, et al. Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med. 2019;45(2):159–71. https://doi.org/10.1007/s00134-019-05519-y.
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012.
Walowski CO, Braun W, Maisch MJ, et al. Reference values for skeletal muscle mass - current concepts and methodological considerations. Nutrients. 2020;12(3):755. https://doi.org/10.3390/nu12030755. Published 2020 Mar 12.
Moon SW, Lee SH, Woo A, et al. Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population. J Cachexia Sarcopenia Muscle. 2022;13(2):955–65. https://doi.org/10.1002/jcsm.12946.
Feng Z, Zhao H, Kang W, et al. Association of paraspinal muscle measurements on chest computed tomography with clinical outcomes in patients with severe coronavirus disease 2019. J Gerontol A Biol Sci Med Sci. 2021;76(3):e78–84. https://doi.org/10.1093/gerona/glaa317.
Zhi J, Shan Q, Liang L, et al. Low skeletal muscle area as a prognostic marker for chronic obstructive pulmonary disease in elderly patients admitted to ICU. Sci Rep. 2019;9(1):19117. https://doi.org/10.1038/s41598-019-55737-z. Published 2019 Dec 13.
Yoshikawa H, Komiya K, Yamamoto T, et al. Quantitative assessment of erector spinae muscles and prognosis in elderly patients with pneumonia. Sci Rep. 2021;11(1):4319. https://doi.org/10.1038/s41598-021-83995-3.
Sun L, Ma H, Du G, et al. Low skeletal muscle area at the T12 paravertebral level as a prognostic marker for community-acquired pneumonia. Acad Radiol. 2022;S1076–6332(21):00618–28. https://doi.org/10.1016/j.acra.2021.12.026.
Guo K, Cai W, Chen Y, et al. Skeletal muscle depletion predicts death in severe community-acquired pneumonia patients entering ICU. Heart Lung. 2022;52:71–5. https://doi.org/10.1016/j.hrtlng.2021.11.013.
Karakioulaki M, Stolz D. Biomarkers in pneumonia-beyond procalcitonin. Int J Mol Sci. 2019;20(8):2004. https://doi.org/10.3390/ijms20082004. Published 2019 Apr 24.
Baek MS, Park S, Choi JH, et al. Mortality and prognostic prediction in very elderly patients with severe pneumonia. J Intensive Care Med. 2020;35(12):1405–10. https://doi.org/10.1177/0885066619826045.
Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73. https://doi.org/10.7326/M14-0698.
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67. https://doi.org/10.1164/rccm.201908-1581ST.
Martin-Loeches I, Torres A. New guidelines for severe community-acquired pneumonia. Curr Opin Pulm Med. 2021;27(3):210–5. https://doi.org/10.1097/MCP.0000000000000760.
Wang X, Jiao J, Wei R, et al. A new method to predict hospital mortality in severe community acquired pneumonia. Eur J Intern Med. 2017;40:56–63. https://doi.org/10.1016/j.ejim.2017.02.013.
Lv C, Chen Y, Shi W, et al. Comparison of different scoring systems for prediction of mortality and ICU admission in elderly CAP population. Clin Interv Aging. 2021;16:1917–29. https://doi.org/10.2147/CIA.S335315. Published 2021 Oct 28.
Frenzen FS, Kutschan U, Meiswinkel N, et al. Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Clin Microbiol Infect. 2018;24(3):306.e1-306.e6. https://doi.org/10.1016/j.cmi.2017.07.007.
Subramanian DN, Musonda P, Sankaran P, et al. Performance of SOAR (systolic blood pressure, oxygenation, age and respiratory rate) scoring criteria in community-acquired pneumonia: a prospective multi-centre study. Age Ageing. 2013;42(1):94–7. https://doi.org/10.1093/ageing/afs158.
Richards G, Levy H, Laterre PF, et al. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 2011;26(1):34–40. https://doi.org/10.1177/0885066610383949.
Ahnert P, Creutz P, Horn K, et al. Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia - results from the prospective observational PROGRESS study. Crit Care. 2019;23(1):110. https://doi.org/10.1186/s13054-019-2316-x. Published 2019 Apr 4.
Zeng Y, Feng Q, Hesketh T, et al. Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study. Lancet. 2017;389(10079):1619–29. https://doi.org/10.1016/S0140-6736(17)30548-2.
Sanz F, Morales-Suárez-Varela M, Fernández E, et al. A composite of functional status and pneumonia severity index improves the prediction of pneumonia mortality in older patients. J Gen Intern Med. 2018;33(4):437–44. https://doi.org/10.1007/s11606-017-4267-8.
Park CM, Kim W, Lee ES, et al. Comparison of frailty index to pneumonia severity measures in older patients with pneumonia. J Am Med Dir Assoc. 2022;23(1):165–9. https://doi.org/10.1016/j.jamda.2021.08.044.
Lv C, Shi W, Pan T, et al. Exploration of aging-care parameters to predict mortality of patients aged 80-years and above with community-acquired pneumonia. Clin Interv Aging. 2022;17:1379–91. https://doi.org/10.2147/CIA.S382347. Published 2022 Sep 20.
Altuna-Venegas S, Aliaga-Vega R, Maguiña JL, et al. Risk of community-acquired pneumonia in older adults with sarcopenia of a hospital from Callao, Peru 2010–2015. Arch Gerontol Geriatr. 2019;82:100–5. https://doi.org/10.1016/j.archger.2019.01.008.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.
Sakakibara T, Shindo Y, Kobayashi D, et al. A prediction rule for severe adverse events in all inpatients with community-acquired pneumonia: a multicenter observational study. BMC Pulm Med. 2022;22(1):34. https://doi.org/10.1186/s12890-022-01819-0. Published 2022 Jan 12.
Ren Y, Zhang L, Xu F, et al. Risk factor analysis and nomogram for predicting in-hospital mortality in ICU patients with sepsis and lung infection. BMC Pulm Med. 2022;22(1):17. https://doi.org/10.1186/s12890-021-01809-8. Published 2022 Jan 7.
Gong L, He D, Huang D, Wu Z, Shi Y, Liang Z. Clinical profile analysis and nomogram for predicting in-hospital mortality among elderly severe community-acquired pneumonia patients with comorbid cardiovascular disease: a retrospective cohort study. BMC Pulm Med. 2022;22(1):312. https://doi.org/10.1186/s12890-022-02113-9. Published 2022 Aug 13.
Sun J, Su J, Xie Y, et al. Plasma IL-6/IL-10 ratio and IL-8, LDH, and HBDH level predict the severity and the risk of death in AIDS patients with pneumocystis pneumonia. J Immunol Res. 2016;2016:1583951. https://doi.org/10.1155/2016/1583951.
Su Y, Ju MJ, Ma JF, et al. Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study. Ann Transl Med. 2019;7(22):660. https://doi.org/10.21037/atm.2019.10.75.
Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752–61.
Dettmer M, Holthaus CV, Fuller BM. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study. Shock. 2015;43:55–61.
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10. https://doi.org/10.1001/jama.2016.0287.
The authors are grateful to the staff of the Radiologic Department of Beijing Chao-Yang Hospital.
This work was supported by the Open Project of Beijing Key Laboratory (grant number: 2020XFN-KFKT-02) and Special Funding Fund for Clinical Research of Wu Jieping Medical Foundation (grant number: 320.6750.2022–26-14).
Ethics approval and consent to participate
This study was approved by the institutional review board of Beijing Chao-Yang Hospital Capital Medical University (approval number: 2022-ke-430) and conducted in accordance with the principles of the amended Declaration of Helsinki. Informed consent was obtained from each patient or their next of kin.
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shang, N., Li, Q., Liu, H. et al. Erector spinae muscle-based nomogram for predicting in-hospital mortality among older patients with severe community-acquired pneumonia. BMC Pulm Med 23, 346 (2023). https://doi.org/10.1186/s12890-023-02640-z
- Severe community-acquired pneumonia
- Erector spinae muscle